Regulations.gov document

Notice of the Denial of a Hearing Request Regarding a Proposal To Refuse To Approve a…

Notice · FDA-2022-N-2390 · posted Mar 7, 2025

Key facts

Document ID FDA-2022-N-2390-0161
Title Notice of the Denial of a Hearing Request Regarding a Proposal To Refuse To Approve a Supplemental New Drug Application for HETLIOZ (Tasimelteon)
Document type Notice
Subtype Notice of Denial
Agency FDA
Docket FDA-2022-N-2390
Posted Mar 7, 2025
Federal Register citation 90 FR 11542
FR document number 2025-03697
Comment period opens Mar 7, 2025
Effective date Mar 7, 2025

At a glance

  • 1–9 Pages
  • 1–9 Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents